Comparison of peptic ulcer disease risk between peritoneal and hemodialysis patients

American Journal of Nephrology

Volumn 32, Issue 3, 2010, Pages 212-218

  Chen, Yung Tai ^a   Yang, Wu Chung ^b   Lin, Chih Ching ^b   Ng, Yee Yung ^b   Chen, Jinn Yang ^b   Li, Szu Yuan ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

End stage renal disease; Helicobacter pylori; Hemodialysis; Peptic ulcer; Peritoneal dialysis

Indexed keywords

ACETYLSALICYLIC ACID; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOALBUMINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT;

ADULT; AGED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIC ULCER; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77954547507     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316963     Document Type: Article

References (31)

1. Cano AE, Neil AK, Kang JY, Barnabas A, Eastwood JB, Nelson SR, Hartley I, Maxwell D: Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterol 2007; 102: 1990-1997.
2. Boyle JM, Johnston B: Acute upper gastrointestinal hemorrhage in patients with chronic renal disease. Am J Med 1983; 75: 409-412.
3. Tseng GY, Lin HJ, Fang CT, Yang HB, Tseng GC, Wang PC, Hung TL, Deng YC, Cheng YT, Huang CH: Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther 2007; 26: 925-933.
4. Milito G, Taccone-Gallucci M, Brancaleone C, Nardi F, Filingeri V, Cesca D, Casciani CU: Assessment of the upper gastrointestinal tract in hemodialysis patients awaiting renal transplantation. Am J Gastroenterol 1983; 78: 328-331.
5. Boccardo P, Remuzzi G, Galbusera M: Platelet dysfunction in renal failure. Semin Thromb Hemost 2004; 30: 579-589.
6. Rockall TA, Logan RF, Devlin HB, Northfield TC: Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-321.
7. Cheung J, Yu A, LaBossiere J, Zhu Q, Fedorak RN: Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointest Endosc 2010; 71: 44-49.
8. Tseng GY, Lin HJ: Factors aside from Helicobacter pylori play an important role in the occurrence of peptic ulcer in dialysis patients. Kidney Int 2009; 75: 1114-1115, author reply 1115.
9. Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y: Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 2009; 75: 96-103.
10. Calvet X, Sanchez-Delgado J, Montserrat A, Lario S, Ramirez-Lazaro MJ, Quesada M, Casalots A, Suarez D, Campo R, Brullet E, Junquera F, Sanfeliu I, Segura F: Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal. Clin Infect Dis 2009; 48: 1385-1391.
11. Wasse H, Gillen DL, Ball AM, Kestenbaum BR, Seliger SL, Sherrard D, Stehman-Breen CO: Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int 2003; 64: 1455-1461.
12. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG: Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14: 415-424.
13. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, Barre PE: Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998; 9: 267-276.
14. Vonesh EF, Moran J: Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10: 354-365.
15. Mattana J, Effiong C, Gooneratne R, Singhal PC: Risk of fatal cerebrovascular accident in patients on peritoneal dialysis versus hemodialysis. J Am Soc Nephrol 1997; 8: 1342-1347.
16. Bloembergen WE, Port FK, Mauger EA, Wolfe RA: A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 184-191.
17. Lee SW, Song JH, Kim GA, Yang HJ, Lee KJ, Kim MJ: Effect of dialysis modalities on gastric myoelectrical activity in end-stage renal disease patients. Am J Kidney Dis 2000; 36: 566-573.
18. Kamiya T, Kobayashi Y, Hirako M, Misu N, Nagao T, Hara M, Matsuhisa E, Ando T, Adachi H, Sakuma N, Kimura G: Gastric motility in patients with recurrent gastric ulcers. J Smooth Muscle Res 2002; 38: 1-9.
19. Love JW: Peptic ulceration may be a hormonal deficiency disease. Med Hypotheses 2008; 70: 1103-1107
20. Aguilera A, Bajo MA, Espinoza M, Olveira A, Paiva AM, Codoceo R, Garca P, Sanchez S, Celadilla O, Castro MJ, Selgas R: Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. Am J Kidney Dis 2003; 42: 787-796.
21. Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, Brown TP, Vessey MP, Murphy M, Colin-Jones DG: Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000; 46: 27-31.
22. Tung CF, Chow WK, Chang CS, Peng YC, Hu WH: The prevalence and significance of hypoalbuminemia in non-variceal upper gastrointestinal bleeding. Hepatogastroenterology 2007; 54: 1153-1156.
23. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity and mortality in endstage renal disease. J Am Soc Nephrol 1996; 7: 728-736.
24. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-1006.
25. Naito Y, Yoshikawa T: Molecular and cellular mechanisms involved in Helicobacter pylori -induced inflammation and oxidative stress. Free Radic Biol Med 2002; 33: 323-336.
26. Naito Y, Yoshikawa T: Oxidative stress involvement and gene expression in indomethacin- induced gastropathy. Redox Rep 2006; 11: 243-253.
27. Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M: Gamma-glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypotheses 2006; 67: 1060-1064.
28. Emdin M, Pompella A, Paolicchi A: Gammaglutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005; 112: 2078-2080.
29. Lee DH, Blomhoff R, Jacobs DR Jr: Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38: 535-539.
30. Chen TS, Luo JC, Chang FY: Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan. J Gastroenterol Hepatol 2010; 919-922.
31. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y: Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-1803.